WEC
HGEN

Winslow Evans & Crocker’s HUMANIGEN, INC. HGEN Stock Holding History

Winslow Evans & Crocker’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$144K Buy
+8,250
New +$98.7K 0.03% 385

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Winslow Evans & Crocker's HGEN Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in HUMANIGEN, INC. (HGEN) in Q4 2020: 8,250 shares worth $144K. The stake represents 0.03% of the portfolio and ranks #385 among its holdings.

39 funds tracked by Wall St. Rank hold HGEN as of Q4 2020.

  • Winslow Evans & Crocker held 8,250 shares of HUMANIGEN, INC. worth $144K as of Q4 2020.
  • HUMANIGEN, INC. was a new Winslow Evans & Crocker position in Q4 2020.
  • HUMANIGEN, INC. made up 0.03% of Winslow Evans & Crocker's portfolio in Q4 2020, its #385 holding.
  • 39 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.